| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/11/2007 | CN1943674A Nettle prodigiosin powders |
| 04/11/2007 | CN1943615A Use of sappan wood alcohol extract inpreparing single medicine for treating self immunological disease |
| 04/11/2007 | CN1943612A Use of honeysukle flower in preparing medicine and health article for improving body immunity |
| 04/11/2007 | CN1943607A Chinese medicine composition and its preparing method |
| 04/11/2007 | CN1943588A Compound nucleotide oral liquor for improving immunity and its preparing method |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309735C Soluble CTL A4 mutant molecules and use thereof |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309733C Pepties from the 16/6id antibody for treating SLE |
| 04/11/2007 | CN1309731C Poria cocos mycellium glucan sulphate derivative and its preparation method and use |
| 04/11/2007 | CN1309720C Piperazine compounds |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309423C Interferon gamma conjugates |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309418C Immunostimulatory oligodeoxynucleotides |
| 04/11/2007 | CN1309417C Use of cell penetrating peptides to generate antitumor immunity |
| 04/11/2007 | CN1309414C Hydrophilic binary systems for the administration of cyclosporine |
| 04/11/2007 | CN1309388C Treatment of inflammatory disorders |
| 04/10/2007 | US7202394 Animal with the mass expression of human gene and test method by using the animal |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202351 Alteration of immune response using pan DR-binding peptides |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202334 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2007 | US7202333 Recombinant soluble fragment of the alpha-subunit polypeptide of human mast cell IgE surface receptor, capable of binding to human IgE; can be used in diagnostic, drug screening and antiallergen applications |
| 04/10/2007 | US7202331 For inducing immune response and administering immunotherapy |
| 04/10/2007 | US7202277 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202252 Xanthines 3-substituted with an arylalkylene or N-heteroarylalkylene group and 8-substituted with a heteroarylalkylene group, e.g. 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(3-pyridyl)methyl]xanthine and 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(4-thiazolyl)methyl]xanthine |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202040 Method for screening compounds which change the binding properties of a protein with a ligand |
| 04/10/2007 | US7201921 A filling formualtion for soft capsule dosage containing loratadine and derivative, a mixture of mono and diglyceride of medium chain fatty acids, povidone and polyoxyethylene sorbitan fatty ester; capsule material is carrageenan |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2336380C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 04/10/2007 | CA2227977C Use in a composition of an extract of at least one labiate |
| 04/10/2007 | CA2209172C Murine monoclonal anti-idiotype antibody 3h1 |
| 04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/05/2007 | WO2007038785A1 Sulfatides for treatment of autoimmune disorders |
| 04/05/2007 | WO2007038519A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 04/05/2007 | WO2007037544A1 Development of method for screening of compound capable of improving the production of regulatory t cell, and method for production of regulatory t cell using immunosuppressive macrolide antibiotic |
| 04/05/2007 | WO2007037430A1 T-cell adhesion molecule and antibody directed against the molecule |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007036791A1 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 04/05/2007 | WO2007036113A1 Medical use of periplocoside a and e |
| 04/05/2007 | WO2007036083A1 Indolyl acrylic derivatives and usage in preparation of immunosuppressive agent thereof |
| 04/05/2007 | WO2007036028A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | WO2007020386A3 Apoe mimetic agents |
| 04/05/2007 | WO2007015003A3 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/05/2007 | WO2007010084A3 Immunostimulatory oligo- and polysaccharides and uses thereof |
| 04/05/2007 | WO2006136859A3 Indoli zine derivatives and their use as crth2 antagonists |
| 04/05/2007 | WO2006133286A3 Treatment of tnf antagonist-resistant inflammatory disorders and related methods |
| 04/05/2007 | WO2006109195A3 Modulation of an immune response by filamentous haemagglutinin |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077260 Vaccines for mycoplasma bovis and methods of use |
| 04/05/2007 | US20070077247 Receptor on the surface of activated T-cells: ACT-4 |
| 04/05/2007 | US20070077242 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 04/05/2007 | CA2624135A1 T-cell adhesion molecule and antibody thereto |
| 04/05/2007 | CA2623957A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | CA2623946A1 Sulfatides for treatment of autoimmune disorders |
| 04/05/2007 | CA2623236A1 Human monoclonal antibodies to cd70 |
| 04/05/2007 | CA2623228A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/04/2007 | EP1770163A2 Antagonists of interleukin-15 |
| 04/04/2007 | EP1770101A1 Antibodies against caspase-8, their preparation and use |
| 04/04/2007 | EP1770093A1 Pyrido¬2,3-d|pyrimidine derivatives as phosphodiesterase inhibitors |
| 04/04/2007 | EP1769807A1 Graft rejection suppressors |
| 04/04/2007 | EP1769806A2 Vaccine against HPV |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1768662A2 Small molecule immunopotentiators and assays for their detection |
| 04/04/2007 | EP1541673B1 Probiotics for pet food applications |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1427405B1 Inflammation-inhibiting compounds |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | CN1942767A Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose |
| 04/04/2007 | CN1942585A Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-lenght virus genome replicative cell having the nucleic acid construct transferred thereinto and metho |
| 04/04/2007 | CN1942469A Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
| 04/04/2007 | CN1942463A 2-aminopyridine derivative |
| 04/04/2007 | CN1942445A Novel quinoline-carbaxamides as JACK3 kinase modulators |
| 04/04/2007 | CN1942197A Method for improved breast milk feeding to reduce the risk of allergy |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1939905A Indole acrylic acid derivative and its use for preparing immune inhibitor |
| 04/04/2007 | CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939532A Use of fungal immunomodulatory protein |